background: PGD is nowadays a well-established alternative to prenatal diagnosis. However, information with respect to couples' motives and profiles for choosing PGD is scarce.
Introduction
Since the first application of PGD for an X-linked condition (Handyside et al., 1990) , PGD has proliferated rapidly throughout the world. At present, more than 4500 pregnancies have been reported (Harper et al., 2010) . Recently, PGD has become available for couples at risk for late-onset diseases and inherited cancer syndromes (Offit et al., 2006; Spits et al., 2007; Jasper et al., 2008; Sagi et al., 2009) .
Although at present, PGD is widely available for many diseases, not much is known about the motives of couples choosing PGD. The literature shows a 38-100% theoretical acceptability of PGD by at risk couples in countries where PGD was prohibited at the time of study (Palomba et al., 1994; Chamayou et al., 1998; Alkuraya and Kilani, 2001; Alsulaiman and Hewison, 2006) . However, a difference may exist between theoretical acceptability and the decision to actually embark on PGD. Furthermore, the profiles and motives of high-risk couples, for whom PGD is intended, are relatively uncharted.
We present a prospective long-term study on couples referred for PGD. We explored the motives of referred couples actually choosing PGD, with the aim of defining factors contributing to their eventual choice. Determinants of couples' initial preference for PGD (PGD intention) and their final choice (PGD use) were studied. Personal characteristics (age and educational level), mode of inheritance of the disorder, clinical impact of the specific genetic disorders, personal experience with the disorder as well as couples' reproductive history were recorded. These latter factors have previously been suggested or shown to effect couples attitudes towards PGD (Miedzybrodzka et al., 1993; Palomba et al., 1994; Snowdon and Green, 1997; Chamayou et al., 1998; Hui et al., 2002; Lavery et al., 2002) . As we presumed that also clinical impact of the disorder may be one of the determining factors for selecting PGD treatment, we divided disorders into four categories (miscarriage risk, lethal childhood disorders, chronic childhood disease and late onset disorders). Furthermore, we studied psychosocial factors that we expected to be of influence for the choice of PGD.
The results of this study may contribute to better understanding of reproductive choices and optimization of counselling couples at a high risk of offspring with a genetic disorder.
Materials and Methods

PGD in the Netherlands
The Maastricht University Medical Centre operates the only approved PGD centre in the Netherlands. PGD is an accepted alternative to prenatal diagnosis in the Netherlands. PGD is available for couples at a high risk of transmitting a genetic or chromosomal abnormality to their offspring (Thornhill et al., 2005) . In the Netherlands, three IVF/PGD cycles are covered by health insurance. Usually, couples are referred for PGD by a clinical geneticist or gynaecologist, after having obtained basic counselling on their reproductive options and after having indicated interest in PGD. Nearly, all couples referred were actually treated in Maastricht. In our centre, couples are offered maximum three cycles, incidentally four, and the mean number of cycles per couple is 2.2. A small minority was treated in collaboration with the PGD centre in Brussels. These included a couple requesting PGD for HLA typing and couples with myotonic dystrophy in the woman, which, because of their risk of cardiovascular and respiratory complications (Aldridge, 1985) , until recently was a contraindication for IVF/PGD in our centre. Aneuploidy screening (PGS) was not included in this study.
Study design
In a 3-year period (2002) (2003) (2004) , all couples referred for PGD were asked for consent to participate in this study. Prior to the first appointment, information leaflets on IVF and PGD and information on this study were sent to the couples. They were scheduled for a counselling session lasting about 1 h with a clinical geneticist. During this session, the couple was provided with detailed information on PGD for their specific situation, including a realistic timeline for test availability, details on IVF by ICSI, single-cell diagnostic procedure and limited success rates of the treatment (Thornhill et al., 2005) . Advantages and disadvantages of PGD compared with relevant alternative reproductive options were also discussed. The clinical geneticist collated relevant information on the couples' obstetric history, family history and health status of both partners. This intake session was immediately followed by an interview by the psychologist. During this interview, a quantitative (semi-structured) questionnaire, including questions on personal experience with the disorder as well as info on socio-psychological factors, was used as guidance (Supplementary data). Answers were verbally scored and filled out on the questionnaire by the psychologist. Where needed, couples had the opportunity to give personal comments and the psychologist could ask for additional qualitative data.
Further data were collected from patient files eventually completed by personal contact with the couple or their physician. As we are the only PGD centre in the Netherlands, we have full data available for all couples who either used or refrained from PGD.
Outcome variables
Two moments of choice with respect to continuing PGD were set as outcome measures; t 0 was set after intake as soon as the couple officially reported their decision (PGD intention) to the clinical geneticist involved. For most couples, this was immediately after intake. For couples who decided to continue treatment, preparation (gynaecological and technical workup) was started (Thornhill et al., 2005) . PGD use (t 1 ) was set 'yes' as soon as the couples started their first PGD cycle. Couples who did not start PGD until March 2010 were contacted by their clinical geneticist in order to confirm possible refraining and to learn reasons for their refraining. They were recorded as non-PGD use. The time lapse between t 0 and t 1 was maximum 8 years. At the closing of data collection, mean female age had reached 38, at which age the chance of still entering the programme is limited.
Study population
The patients' flow is shown in Fig. 1 . A total of 292 couples were initially included. At t 0 , 123 couples refrained from treatment, whereas 169 couples intended to start PGD. In the following years, six couples changed their minds regarding PGD treatment (no to yes): three had a(nother) termination of pregnancy (TOP) in the meantime and three couples changed their minds without specific motivation. Another 26 couples (9.8%) refrained from treatment during or after the work-up for PGD: 12 women had a spontaneous pregnancy before starting PGD, 3 couples had relationship problems, 2 couples did not have health insurance, 1 couple refrained because of the health risk for the female, and the remaining 8 couples refrained without mentioning a specific reason.
Finally, 28 couples were considered unsuitable for PGD for ethical, gynaecological or technical reasons. They were excluded from the present study since they were not given the chance to choose to have PGD at t 1 .
Thus, 264 couples were included for analysis. At t 0 , 141 initially preferred PGD (PGD intention 53.4%). At t 1 , 121 couples had actually started PGD and 143 had refrained from treatment (PGD use 45.8%).
Determinants
Couples' characteristics
Data on age and level of education (low, middle, high) were collected and compared with the age and education level of the general population in the Netherlands (CBS-National Office for Statistics). 
Clinical impact of the specific genetic disorders
Genetic characteristics of disorders
Mode of inheritance was recorded as chromosomal (CH) (translocations, inversions, insertions and mosaic Turner syndrome), autosomal dominant (AD), autosomal recessive (AR), X-linked (XL) and miscellaneous (MS).
We also recorded which of the two partners was the carrier (Table III) .
Profiles and motives for PGD
Reproductive history and personal experience
Fertility was scored in terms of 'infertility' (simultaneous IVF indication), 'reduced fertility' for couples in need of fertility supporting treatment other than IVF, or 'normal or not yet started' for couples who had achieved a previous spontaneous pregnancy or who had not previously tried to conceive. Miscarriages, terminations of pregnancy (TOP) or (un)complicated pregnancies were recorded, if applicable (yes/no).
Couples' experience with the disease was measured in terms of the presence of an affected living child, loss of a child due to the genetic disorder, or the presence of at least one healthy child (Table III) . Table IV shows the items scored by the psychologist by means of the questionnaire. The choice of the items is based on the literature available at that time, completed with items constructed on the basis of our clinical impressions in the preceding years. Information was collected for male and female partners separately. Openness regarding discussion of PGD treatment was recorded on a five-point scale ranging from 'taboo' to 'tell everybody'. The amount of social support was scored on a five-point scale ranging from 'much support' to 'insufficient support'. The acceptability or availability of an alternative reproductive option was measured on a four-point scale ranging from 'no alternative' to 'preferred alternative'.
Psychosocial factors
In addition, it was documented whether or not the two partners agreed with the reproductive decision. The time pressure for PGD treatment was quantified by recording on a four-point scale ranging from 'no time pressure (.10 years)' to 'high time pressure (,3 years)'. The time pressure was an objectively estimated measure based on the remaining years till reaching the female age of 40 (exclusion criterium IVF/PGD) and the presence of a late onset disorder.
Statistical analyses
Comparisons of the couples' characteristics with the general population were performed by x 2 tests for comparison of education level, while for comparing mean age, a t-test was used. Logistic regression analyses were performed to evaluate the contribution of the determinants to PGD intention (t 0 ) and PGD use (t 1 ). Analyses were performed both unadjusted and adjusted for potential confounders. These confounders were identified from the unadjusted regression analyses. In the multivariable logistic regression analysis for PGD intention, we corrected for the significant confounders 'presence of an affected child', 'miscarriages' and 'alternative reproductive option'. In the multivariable logistic regression analysis for PGD use, we corrected for the significant confounders 'presence of an affected child', 'pregnancy terminations' and 'alternative reproductive options'. All P-values are twosided and results were considered statistically significant if P ≤ 0.05 and 95% confidence intervals (CI) of the odds ratios (ORs) were calculated.
The analyses were conducted with the SAS version 9.1 software package (SAS Institute Inc., Cary, NC, USA).
Results
Couples' characteristics
The mean age was 31.1 years ] for the female partners and 33.3 years [range 22-51 (SD 4.78)] for the male partners. Educational levels of males in our study [lower, middle, high: resp., 23.6%, 39.8%, 36.6% (n ¼ 246)] as well as females [lower, middle, high: resp. 18.7%, 43.9%, 37.4%) (n ¼ 246)] show a slight, but non-significant overrepresentation of couples with a higher education compared with the general population of the Netherlands (CBS-National Office for Statistics). Neither educational level nor age contributed significantly to the choice for PGD [female age (t 1 : OR 1.0, 95% CI 0.9 -1.1), male age (t 1 : OR 1.0, 95% CI 0.96-1.07)].
Logistic regression analyses
The adjusted ORs are presented, since in most cases, unadjusted and adjusted ORs did not differ substantially. An overview of the results is listed in Table V . Only considerable differences between unadjusted and adjusted results will be discussed in more detail. 
Clinical impact of the specific genetic disorders
None of the variables measuring impact of the specific disorders influenced the PGD choice (Table V) .
Genetic characteristics of the disorders
Couples at risk of transmitting AR disorders showed significantly reduced PGD use compared with couples with an AD disorder. However, after adjusted analysis, this effect disappeared (Table V) . In the group of AD and CH inheritance, females were significantly more often carriers than males (48/27 and 47/36, respectively). Analyses of the gender of the carrier for both modes of inheritance did not show any effect on the PGD intention (t 0 ) or the PGD use (t 1 ) (data not shown).
Reproductive history and personal experience
Infertility tended to show increased PGD intention and significantly increased PGD use (OR 2.3, 95% CI 1.0 -5.2) compared with couples with normal fertility (Table V) . Subfertility did not show this effect. Couples with a history of miscarriages showed an increased PGD intention (OR 3.0, 95% CI 1.5-5.8). However, the effect of miscarriages lost significance and PGD use was comparable to couples without such experience. In contrast, the experience of a TOP moderately increased PGD intention, but in time, actual PGD use was significantly increased (OR 3.1, 95% CI 1.5-6.4) compared with couples without such experience.
In contrast to the clinical impact of the genetic disorder, the couples' 'personal experience' with the disease did contribute significantly to the choice. Couples with a living affected child showed a tendency towards reduced PGD intention (t 0 : OR 0.5, 95% CI 0.3 -1.1) compared with couples without an affected child. In time, this effect appeared to grow even stronger, resulting in a significant decrease in PGD use (t 1 : OR 0.3, 95% CI 0.1 -0.6). Interestingly, the experience of the loss of a child due to the genetic disorder showed the opposite effect: PGD intention was significantly increased, whereas PGD use was not affected.
Psychosocial factors
The strongest effect on both PGD intention and PGD use was the absence of a morally acceptable or practical alternative, labelled 'no alternative' (Table V) . Unadjusted analyses showed similar effects of these variables in both males and females. However, after adjusted analyses, this effect was only observed in females (t 0 : OR 14.4, 95% CI 2.8-73.9 and t 1 : OR 12.1, 95% CI 2.3-63.4). This finding was in line with the unadjusted analysis of 'agreement of reproductive decision' between partners. Here we observed that if the female was less inclined towards PGD than her husband, the couple was less likely to express PGD intention or ultimately PGD use. However, in adjusted analysis, this effect of disagreement disappeared.
The opposite gender effect was seen in the reported openness: males stating 'openness to only family and friends' showed significantly decreased use of PGD in comparison to males reporting 'openness to everybody' (OR 0.4, 95% CI 0.2-0.9). Likewise, the amount of support experienced by males only contributed to PGD use. Males reporting 'insufficient support' showed a tendency towards decreased PGD intention and significantly decreased PGD use (t 1 : OR 0.2, 95% CI 0.0 -1.0). In females, this effect was not significant. Finally, the level of time pressure did not show any correlation to PGD intention or to PGD use.
Discussion
We present a long-term prospective study on PGD use and the profiles and motives of couples referred for PGD. While 53% of the couples initially tended to use PGD, only 46% of the couples actually embarked on PGD treatment. Our study shows that couples with infertility problems or couples who underwent one or more pregnancy terminations were more prone to opt for PGD, while the presence of a living affected child was a negative predictor for the eventual use of PGD. Couples with a history of miscarriage(s) showed increased PGD intention but many refrained from factual treatment.
Neither the clinical impact of the disorder nor the mode of inheritance determined the choice of PGD. So, we conclude that the actual experience of couples is the main determining factor to choose for PGD, rather than theoretical data on recurrence risks or type of disorder. The preference for PGD in the woman rather than possible alternatives turned out to be the strongest psychological determinant for PGD. Other psychological factors such as time pressure, social support or openness were less important. As the partners were interviewed together, we cannot exclude the possibility of partners mutually influencing each other's responses. A correlation between increased PGD interest and fertility problems was found in several studies and is in line with our results (Miedzybrodzka et al., 1993; Chamayou et al., 1998; Hui et al., 2002; Borkenhagen et al., 2007) . The simple explanation may be that these infertile couples are dependent on assisted reproduction techniques to conceive.
We observed a rather paradoxical shift between PGD intention and PGD use in the couples who have an affected child. Loss of an affected child resulted in increased PGD intention, whereas PGD use was not significantly affected. The presence of a living affected child, however, led to slightly decreased PGD intention and significantly decreased PGD use. Contrary to our findings, a positive attitude towards PGD was observed in subjects with an affected child in three other studies (Chamayou et al., 1998; Hui et al., 2002; Alsulaiman and Hewison, 2006) . We assume that the theoretical setting of these studies in countries where PGD had not yet, or only recently, been introduced (Saudi Arabia, Italy, Hong Kong) and the substantial number of females who were pregnant at the time of study (not reported/30, 155/155 and 24/141, respectively) might have contributed to a more positive attitude towards PGD, since doubts and fears about their current pregnancy and the unknown outcome might have predisposed them to demonstrate a hypothetical willingness to use PGD. On the other hand, the shift towards reduced PGD intention among couples having an affected child might be explained by the impracticality of actually combining an invasive and time-consuming procedure like PGD/IVF with the demanding and time-consuming care for an affected child. Another reason for this reduced PGD intention may be that couples feel uneasy towards their affected child, as if by performing PGD for subsequent offspring, they 'reject' the previous child. This effect, however, would be probably even stronger concerning PND with a possible TOP.
Couples who have experienced TOP might have a more fundamental motive for PGD driven by the desire to avoid another pregnancy termination. In the literature, some studies show a positive attitude towards PGD among couples with a previous TOP (Pergament, 1991; Palomba et al., 1994; Chamayou et al., 1998) , while others found no such correlation (Miedzybrodzka et al., 1993; Hui et al., 2002; Farra et al., 2008) .
We speculate that the choice of PGD in the group of patients with previous miscarriages might be prompted primarily by the desire to achieve a successful pregnancy. The actual method of choice to reach this goal (PGD or spontaneously) seems to be of minor importance. In our study, 9 out of 16 couples with previous miscarriage(s) eventually refrained because of a current pregnancy, compared with 3 out of 10 couples without a previous miscarriage. In the 26 refraining couples, 62% (16/26) showed a history of miscarriages, compared with 33% (88/264) of the total referred couples.
In contrast to our findings, in a recent qualitative study, couples reported 'experiencing previous miscarriages' to be a common motive for using PGD (Karatas et al., 2010) . This apparent discrepancy might be caused by the different design of the studies. We studied a large and heterogeneous group of couples who did and did not Lethal childhood disorder 0.6 0.2 -1.5 0.6 0.2-2.3 0.6 0.2-1.5 0.8 0.2-3.0
Chronic childhood disease 1.0 0.5 -1.9 1.5 0.6-3.5 1.1 0.5-2.1 1.7 0.7-3.9
Late onset disorder Ref.
Ref.
Specific disease characteristics
Mental retardation or (progressive) cognitive impairment start PGD and performed a quantitative analyses. Karatas studied a selected small sample (n ¼ 14) during PGD treatment in a qualitative way. Our finding that the clinical impact of the disorder was not of influence is in contrast with studies on the acceptability of PGD in the general population. In Germany, a correlation between the increased clinical impact of disorders and the acceptability as well as Intended Use of PGD was found in a randomly selected population (Meister et al., 2005; Borkenhagen et al., 2007) . Again the theoretical setting of these studies might have influenced study results in favour of PGD. However, we assume that both the general acceptability of PGD and other reproductive alternatives are affected by their (expected) impact. Furthermore, in our study design, we cannot rule out a pre-selection of PGD candidates according to higher or lower impact of the disease before intake to our PGD centre.
All in all, the strongest predictor for PGD was the woman's preference for PGD measured in the 'alternative reproductive option'. From this finding, we conclude that the opinion of the female partner is dominant in the decision-making process concerning PGD.
Comparing our study with others, we observed four major differences. First, our study population consists solely of patients referred for PGD, who were already relatively well informed before referral. Other study samples consisted of couples approached actively for their increased risk of affected offspring (Miedzybrodzka et al., 1993; Palomba et al., 1994; Snowdon and Green, 1997; Chamayou et al., 1998; Alkuraya and Kilani, 2001; Hui et al., 2002; Alsulaiman and Hewison, 2006; Farra et al., 2008) or of a random sample from the general population (Meister et al., 2005; Finck et al., 2006; Borkenhagen et al., 2007) . Two studies have explored couples' attitudes toward PGD prior to PGD or IVF treatment (Katz et al., 2002) or their experiences and attitudes after undergoing PGD or IVF treatment (Lavery et al., 2002) .
Second, our study group is large and heterogeneous, consisting of couples with a high risk of miscarriage (25 -50%) or a high risk of having a child with a serious genetic disorder with different modes of inheritance, whereas other studies describe couples at risk of transmitting (mainly) autosomal recessive disorders (Pergament, 1991; Miedzybrodzka et al., 1993; Palomba et al., 1994; Snowdon and Green, 1997; Chamayou et al., 1998; Hui et al., 2002; Lavery et al., 2002; Farra et al., 2008) .
Third, there is a great gap in prior knowledge about PGD and information supplied to participants between our study and others. Our population is generally well informed about the existence of PGD, and all our participants received basic information prior to being referred. Unawareness of PGD in the subjects studied in the literature is generally high (40 -100%) (Snowdon and Green, 1997; Alkuraya and Kilani, 2001; Meister et al., 2005; Alsulaiman and Hewison, 2006; Borkenhagen et al., 2007; Musters et al., 2010) . Detailed information on PGD supplied to participants is limited: in only three other studies were participants provided with oral information about PGD (Alkuraya and Kilani, 2001; Farra et al., 2008; Alsulaiman et al., 2010) . Other populations received only limited written information about PGD by way of leaflets (Pergament, 1991; Miedzybrodzka et al., 1993; Palomba et al., 1994; Snowdon and Green, 1997; Chamayou et al., 1998; Hui et al., 2002; Meister et al., 2005; Musters et al., 2010) or even only short definitions (Lammens et al., 2009; Quinn et al., 2009 Quinn et al., , 2010 .
Fourth, PGD accessibility varies from one country to another. Internationally, most studies have been carried out in countries (Germany, Italy, Saudi Arabia and Lebanon) where PGD had not (yet) been legalized (Palomba et al., 1994; Chamayou et al., 1998; Alkuraya and Kilani, 2001; Meister et al., 2005; Alsulaiman and Hewison, 2006; Finck et al., 2006; Borkenhagen et al., 2007; Farra et al., 2008) . Other studies have explored the acceptability of new indications for PGD (HLA typing or inheritable cancer) in countries where PGD was already operational (Hui et al., 2009; Lammens et al., 2009) .
As a consequence, in the literature, choices of PGD were measured on a rather hypothetical basis.
One would expect our population of referrals to be biased towards a more positive attitude to PGD. However, in spite of this selection bias, in our study, the percentage of couples intending to start PGD (53%) is relatively low compared with the 19-100% of couples at risk of transmitting (mainly) autosomal recessive disorders described in the literature (Pergament, 1991; Miedzybrodzka et al., 1993; Palomba et al., 1994; Snowdon and Green, 1997; Chamayou et al., 1998; Hui et al., 2002; Lavery et al., 2002; Farra et al., 2008; Quinn et al., 2009) . The theoretical setup of most studies, combined with the limited information given about the disadvantages, might result in a more positive (theoretical) attitude towards PGD. In our opinion, it is only after extensive counselling about the burden and risk of IVF treatment, the limited success rate and the time-consuming procedure, that couples are able to make a well-informed choice for or against PGD.
Our data confirm that the original reason for developing PGD, namely to offer an alternative for prenatal diagnosis, is still valid. On the other hand, we have shown that most normal fertile couples with an uncomplicated reproductive history and without obvious moral or religious objections to PGD decide to refrain from PGD after extensive counselling. They presumably show preference for prenatal diagnostic testing. This is in accordance with the results of others (Miedzybrodzka et al., 1993; Palomba et al., 1994; Snowdon and Green, 1997) . Since PGD in the Netherlands is covered by the general health insurance, generalizability of our study to countries without such reimbursement might be limited.
In conclusion, the overall picture obtained from this study is that around 50% of the couples referred for PGD actually continue to PGD treatment. PGD is particularly attractive for couples who have terminated one or more pregnancies and for infertile couples. The female preference for PGD over alternatives is a very strong determinant indeed of couples eventually using PGD. On the other hand, prenatal diagnosis is the most likely alternative for couples who have no experience of prenatal testing. This information can be of value in reproductive counselling of couples with an increased genetic risk to enable them to make a well-motivated choice.
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